Université de Sherbrooke
Quick facts
Marketed products
- Brand name travoprost
- CycloSPORINE Ophthalmic · Ophthalmology
Cyclosporine is a calcineurin inhibitor that suppresses T-cell activation and reduces inflammatory cytokine production in the eye. - Generic travoprost · Ophthalmology
Travoprost is a prostaglandin F analog that binds to the prostaglandin F (FP) receptor to increase uveoscleral outflow of aqueous humor, thereby reducing intraocular pressure. - Hypertonic saline 3% bolus administration · Neurology
Hypertonic saline 3% creates an osmotic gradient that draws fluid from intracellular and interstitial spaces into the intravascular compartment, reducing intracranial pressure and cellular edema. - Intrathecal Morphine/Sufentanil · Pain Management
Intrathecal morphine and sufentanil are opioid agonists that bind to opioid receptors in the spinal cord to block pain signal transmission. - Levothyroxine supplementation
Phase 3 pipeline
- Androgen blockade + radiation therapy · Oncology
Androgen blockade suppresses testosterone-driven prostate cancer cell growth, while radiation therapy delivers targeted cytotoxic damage to tumor cells. - Metformin, glyburide and insulin · Diabetes
This combination therapy addresses type 2 diabetes through three complementary mechanisms: metformin reduces hepatic glucose production, glyburide stimulates pancreatic insulin secretion, and insulin provides direct glucose-lowering action. - tinidazole+fluconazole vs metronidazole+clotrimazole · Infectious Diseases
Tinidazole and fluconazole work by inhibiting the synthesis of DNA and RNA in susceptible fungi and bacteria, respectively.
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors: